Article ; Online: Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art.
2016 Volume 161, Page(s) 1–10
Abstract: Primaquine is the only antimalarial drug available to clinicians for the treatment of relapsing forms of malaria. Primaquine development and usage dates back to the 1940s and has been administered to millions of individuals to treat and eliminate malaria ...
Abstract | Primaquine is the only antimalarial drug available to clinicians for the treatment of relapsing forms of malaria. Primaquine development and usage dates back to the 1940s and has been administered to millions of individuals to treat and eliminate malaria infections. Primaquine therapy is not without disadvantages, however, as it can cause life threatening hemolysis in humans with glucose-6-phosphate dehydrogenase (G6PD) deficiency. In addition, the efficacy of primaquine against relapsing malaria was recently linked to CYP 2D6 mediated activation to an active metabolite, the structure of which has escaped definitive identification for over 75years. CYP 2D6 is highly polymorphic among various human populations adding further complexity to a comprehensive understanding of primaquine pharmacology. This review aims to discuss primaquine pharmacology in the context of state of the art understanding of CYP 2D6 mediated 8-aminoquinoline metabolic activation, and shed light on the current knowledge gaps of 8-aminoquinoline mechanistic understanding against relapsing malaria. |
---|---|
MeSH term(s) | Animals ; Antimalarials/adverse effects ; Antimalarials/metabolism ; Antimalarials/pharmacokinetics ; Antimalarials/pharmacology ; Cytochrome P-450 CYP2D6/genetics ; Cytochrome P-450 CYP2D6/metabolism ; Drug Interactions ; Humans ; Metabolomics ; Polymorphism, Genetic ; Primaquine/adverse effects ; Primaquine/metabolism ; Primaquine/pharmacokinetics ; Primaquine/pharmacology ; Prodrugs/adverse effects ; Prodrugs/metabolism ; Prodrugs/pharmacology |
Chemical Substances | Antimalarials ; Prodrugs ; Cytochrome P-450 CYP2D6 (EC 1.14.14.1) ; Primaquine (MVR3634GX1) |
Language | English |
Publishing date | 2016 |
Publishing country | England |
Document type | Journal Article ; Review ; Research Support, Non-U.S. Gov't |
ZDB-ID | 194735-7 |
ISSN | 1879-016X ; 0163-7258 |
ISSN (online) | 1879-016X |
ISSN | 0163-7258 |
DOI | 10.1016/j.pharmthera.2016.03.011 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1183: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.